BHST 12.50 ▲ 3.91% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioHarvest Sciences Inc. ...

    NASDAQ: BHST · Real-Time Price · USD
    12.50
    0.47 (3.91%)
    At close: Oct 15, 2025, 1:35 PM
    3.91%
    Bid 11.93
    Market Cap 216.65M
    Revenue (ttm) 30.17M
    Net Income (ttm) -12.06M
    EPS (ttm) -0.69
    PE Ratio (ttm) -18.12
    Forward PE -316.75
    Analyst Buy
    Dividends n/a
    Ask 12.32
    Volume 23,825
    Avg. Volume (20D) 50,207
    Open 12.23
    Previous Close 12.03
    Day's Range 11.84 - 12.72
    52-Week Range 4.66 - 12.80
    Beta 1.47
    Ex-Dividend Date n/a

    About BHST

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol BHST
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for BHST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    BioHarvest Sciences Inc. Common Stock is scheduled to release its earnings on Nov 24, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    news image

    3 weeks ago · proactiveinvestors.com

    BioHarvest balance sheet gets $14.7m boos, including $11m of new investment

    BioHarvest Sciences Inc. (NASDAQ:BHST) has strengthened its finances by pulling in $10.9 million in fresh investment and trimming $3.8 million in debt through a series of deals involving warrants and ...

    news image

    3 weeks ago · newsfilecorp.com

    BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction

    Rehovot, Israel--(Newsfile Corp. - September 22, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis te...

    news image

    1 month ago · seekingalpha.com

    BioHarvest Sciences Inc. (BHST) Virtual Investor Webinar Call (Transcript)

    BioHarvest Sciences Inc. (NASDAQ:BHST ) Virtual Investor Webinar Conference September 10, 2025 01:00 PM ET Company Participants Ilan Sobel - Chief Executive Officer Zaki Rakib - Co-Founder, Executive ...

    news image

    1 month ago · proactiveinvestors.com

    BioHarvest Sciences achieves large-scale production of plant-based exosomes

    BioHarvest Sciences Inc. (NASDAQ:BHST) announced it has successfully produced plant-based exosomes at scale in its proprietary bioreactors, a development the company says represents a breakthrough in ...

    news image

    1 month ago · newsfilecorp.com

    BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale

    Exosomes Produced in the Liquid Media of the BioHarvest Unique Large-Scale Bioreactors Add Potential New Revenue Stream from Products and CDMO Opportunities Rehovot, Israel--(Newsfile Corp. - Septembe...

    news image

    1 month ago · newsfilecorp.com

    BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET

    Rehovot, Israel--(Newsfile Corp. - September 2, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis techn...

    news image

    2 months ago · zacks.com

    BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Misses Revenue Estimates

    BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.04 per share a year ago.

    news image

    2 months ago · seekingalpha.com

    BioHarvest Sciences Inc. (BHST) Q2 2025 Earnings Call Transcript

    BioHarvest Sciences Inc. (NASDAQ:BHST ) Q2 2025 Earnings Conference Call August 11, 2025 8:00 AM ET Company Participants Bar Dichter - Chief Financial Officer Ilan Sobel - Chief Executive Officer Conf...

    news image

    2 months ago · proactiveinvestors.com

    BioHarvest Sciences Q2 revenue jumps on VINIA growth

    BioHarvest Sciences Inc. (NASDAQ:BHST) reported a 41% rise in second-quarter revenue, driven by growth in its VINIA product line and contributions from its contract development and manufacturing (CDMO...

    news image

    2 months ago · newsfilecorp.com

    BioHarvest Sciences Reports Second Quarter 2025 Financial Results

    Robust 41% Year-Over-Year Revenue Growth, Driven by Strong Core Capsule and New Product Sales Rehovot, Israel--(Newsfile Corp. - August 11, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ...

    Add to Watchlist